Parkinson Research Consortium
Our Team
We benefit from the expertise and efforts of the following group of elite researchers:
David Park, PhD - an expert in neuronal death using mouse models of Parkinson's disease
David Grimes, M.D., FRCPC - neurologist, specializing in Parkinson's disease and biomarker analysis
Michael Schlossmacher, M.D., FRCPC - neurologist, specializing in Parkinson's disease and biomarker analysis
Paul Albert, PhD - an expert in dopamine signaling within the brain
Steffany Bennett, PhD - lipid biochemist, cell biologist, and systems neuroscientist studying neurodegeneration and neuroregeneration
Dennis Bulman, PhD - geneticist, an expert at the identification of human disease genes
Antonio Colavita, PhD - molecular biologist and an expert in C. elegans worm genetics and development
Mark Ekker, PhD - internationally renowned developmental biologist who uses zebra fish as a model to study cell death mechanisms
Heidi McBride, PhD – scientist examining the molecular machinery that governs mitochondrial dynamics
Tilak Mendis, M.D., FRCPC - neurologist with expertise in cognitive dementia who performs clinical research in neurodegenerative disease
Johnny Ngsee, PhD - expert in the processes that determine information traffic among brain cells
Robin Parks, PhD - scientist with research expertise in gene therapy using viruses
Robert Screaton, PhD - scientist working to identify the molecular machinery used by cells to respond to extracellular cues.
Ruth Slack, PhD - expert in stem cell biology and neuronal death
Mario Tiberi, PhD - scientist exploring how dopamine signaling works in the brain
Vance Trudeau, PhD - expert in biology
John Woulfe, M.D., FRCPC, PhD - neuropathologist, exploring why abnormal inclusions form within dying brain cells
